In Vivo Mutagenesis of the Insulin Receptor*

Mice bearing targeted gene mutations that affect insulin receptor (Insr) function have contributed important new information on the pathogenesis of type 2 diabetes. Whereas complete Insr ablation is lethal, conditional mutagenesis in selected tissues has more limited consequences on metabolism. Studies of mice with tissue-specific ablation of Insr have indicated that both canonical (e.g. muscle and adipose tissue) and noncanonical (e.g. liver, pancreatic β-cells, and brain) insulin target tissues can contribute to insulin resistance, albeit in a pathogenically distinct fashion. Furthermore, experimental crosses of Insr mutants with mice carrying mutations that affect insulin action at more distal steps of the insulin signaling cascade have begun to unravel the genetics of type 2 diabetes. These studies are consistent with an oligogenic inheritance, in which synergistic interactions among few alleles may account for the genetic susceptibility to diabetes. In addition to mutant alleles conferring an increased risk of diabetes, these studies have uncovered mutations that protect against insulin resistance, thus providing proof-of-principle for the notion that certain alleles may confer resistance to diabetes.

[1]  S. Tilghman,et al.  Glyceroneogenesis and the Triglyceride/Fatty Acid Cycle* , 2003, Journal of Biological Chemistry.

[2]  Matthias Blüher,et al.  Extended Longevity in Mice Lacking the Insulin Receptor in Adipose Tissue , 2003, Science.

[3]  Abner Louis Notkins,et al.  Immunologic and Genetic Factors in Type 1 Diabetes* , 2002, The Journal of Biological Chemistry.

[4]  Y. Kido,et al.  Effects of Mutations in the Insulin-like Growth Factor Signaling System on Embryonic Pancreas Development and β-Cell Compensation to Insulin Resistance* , 2002, The Journal of Biological Chemistry.

[5]  D. Accili,et al.  Regulation of insulin action and pancreatic β-cell function by mutated alleles of the gene encoding forkhead transcription factor Foxo1 , 2002, Nature Genetics.

[6]  Gary Ruvkun,et al.  Longevity: Don't hold your breath , 2002, Nature.

[7]  C. Kahn,et al.  Adipose tissue selective insulin receptor knockout protects against obesity and obesity-related glucose intolerance. , 2002, Developmental cell.

[8]  C. Mantzoros,et al.  Effects of acute and chronic administration of the melanocortin agonist MTII in mice with diet-induced obesity. , 2002, Diabetes.

[9]  M. Stoffel,et al.  β-cell–specific deletion of the Igf1 receptor leads to hyperinsulinemia and glucose intolerance but does not alter β-cell mass , 2002, Nature Genetics.

[10]  J. Shaw,et al.  Global and societal implications of the diabetes epidemic , 2001, Nature.

[11]  C. Kahn,et al.  Insulin signalling and the regulation of glucose and lipid metabolism , 2001, Nature.

[12]  Y. Kido,et al.  Preserved Pancreatic β-Cell Development and Function in Mice Lacking the Insulin Receptor-Related Receptor , 2001, Molecular and Cellular Biology.

[13]  G. Shulman,et al.  Functional inactivation of the IGF-I and insulin receptors in skeletal muscle causes type 2 diabetes. , 2001, Genes & development.

[14]  M. Bucan,et al.  A role for AMP-activated protein kinase in contraction- and hypoxia-regulated glucose transport in skeletal muscle. , 2001, Molecular cell.

[15]  C. Kenyon.  A Conserved Regulatory System for Aging , 2001, Cell.

[16]  G. Shulman,et al.  Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver , 2001, Nature.

[17]  G. Shulman,et al.  Contrasting Effects of IRS-1 Versus IRS-2 Gene Disruption on Carbohydrate and Lipid Metabolism in Vivo * , 2000, The Journal of Biological Chemistry.

[18]  A. Hattersley,et al.  Searching for Type 2 Diabetes Genes in the Post-genome Era , 2000, Trends in Endocrinology & Metabolism.

[19]  Daniel A. Pollard,et al.  Hypoglycaemia, liver necrosis and perinatal death in mice lacking all isoforms of phosphoinositide 3-kinase p85α , 2000, Nature Genetics.

[20]  Rüdiger Klein,et al.  Role of Brain Insulin Receptor in Control of Body Weight and Reproduction , 2000 .

[21]  C. Kahn,et al.  Targeted disruption of the glucose transporter 4 selectively in muscle causes insulin resistance and glucose intolerance , 2000, Nature Medicine.

[22]  C. Kahn,et al.  Redistribution of substrates to adipose tissue promotes obesity in mice with selective insulin resistance in muscle. , 2000, The Journal of clinical investigation.

[23]  A. Schäffer,et al.  Genetic modifiers of the insulin resistance phenotype in mice. , 2000, Diabetes.

[24]  Y. Kido,et al.  Tissue-specific insulin resistance in mice with mutations in the insulin receptor, IRS-1, and IRS-2. , 2000, The Journal of clinical investigation.

[25]  D. Hanahan,et al.  Altered function of insulin receptor substrate-1-deficient mouse islets and cultured beta-cell lines. , 1999, The Journal of clinical investigation.

[26]  C. Kahn,et al.  Exercise modulates postreceptor insulin signaling and glucose transport in muscle-specific insulin receptor knockout mice. , 1999, The Journal of clinical investigation.

[27]  Sironi,et al.  Insulin: new roles for an ancient hormone , 1999, European journal of clinical investigation.

[28]  Z Trajanoski,et al.  Impaired glucose transport as a cause of decreased insulin-stimulated muscle glycogen synthesis in type 2 diabetes. , 1999, The New England journal of medicine.

[29]  H. Kuwano,et al.  Insulin receptor-related receptor is expressed in pancreatic beta-cells and stimulates tyrosine phosphorylation of insulin receptor substrate-1 and -2. , 1999, Diabetes.

[30]  A. Cherrington,et al.  Banting Lecture 1997. Control of glucose uptake and release by the liver in vivo. , 1999, Diabetes.

[31]  A. Costantino,et al.  Insulin Receptor Isoform A, a Newly Recognized, High-Affinity Insulin-Like Growth Factor II Receptor in Fetal and Cancer Cells , 1999, Molecular and Cellular Biology.

[32]  B. Kennedy,et al.  Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene. , 1999, Science.

[33]  C. Kahn,et al.  Tissue-Specific Knockout of the Insulin Receptor in Pancreatic β Cells Creates an Insulin Secretory Defect Similar to that in Type 2 Diabetes , 1999, Cell.

[34]  Y. Matsuzawa,et al.  Increased insulin sensitivity and hypoglycaemia in mice lacking the p85α subunit of phosphoinositide 3–kinase , 1999, Nature Genetics.

[35]  Nancy J. Cox,et al.  Loci on chromosomes 2 (NIDDM1) and 15 interact to increase susceptibility to diabetes in Mexican Americans , 1999, Nature Genetics.

[36]  C. Kahn,et al.  A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance. , 1998, Molecular cell.

[37]  Y. Kido,et al.  Impaired glucose tolerance in mice with a targeted impairment of insulin action in muscle and adipose tissue , 1998, Nature Genetics.

[38]  G. Ruvkun,et al.  Aging, life span, and senescence. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[39]  S. Woods,et al.  Obesity, diabetes and the central nervous system , 1998, Diabetologia.

[40]  G. Shulman,et al.  Disruption of IRS-2 causes type 2 diabetes in mice , 1998, Nature.

[41]  G. Ruvkun,et al.  An insulin-like signaling pathway affects both longevity and reproduction in Caenorhabditis elegans. , 1998, Genetics.

[42]  G. Ruvkun,et al.  The Fork head transcription factor DAF-16 transduces insulin-like metabolic and longevity signals in C. elegans , 1997, Nature.

[43]  D. Accili,et al.  Growth-promoting interaction of IGF-II with the insulin receptor during mouse embryonic development. , 1997, Developmental biology.

[44]  Koutarou D. Kimura,et al.  daf-2, an insulin receptor-like gene that regulates longevity and diapause in Caenorhabditis elegans. , 1997, Science.

[45]  C. Kahn,et al.  Development of a Novel Polygenic Model of NIDDM in Mice Heterozygous for IR and IRS-1 Null Alleles , 1997, Cell.

[46]  B. Lamothe,et al.  Targeted disruption of the insulin receptor gene in the mouse results in neonatal lethality. , 1996, The EMBO journal.

[47]  H. Benecke,et al.  Impaired Insulin Signaling in Skeletal Muscles from Transgenic Mice Expressing Kinase-deficient Insulin Receptors (*) , 1995, The Journal of Biological Chemistry.

[48]  Simeon I. Taylor,et al.  Lilly Lecture: Molecular Mechanisms of Insulin Resistance: Lessons From Patients With Mutations in the Insulin-Receptor Gene , 1992, Diabetes.

[49]  D. Accili,et al.  Targeted inactivation of the insulin receptor gene in mouse 3T3-L1 fibroblasts via homologous recombination. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[50]  J. Leahy,et al.  Insulin-like growth factor-I at physiological concentrations is a potent inhibitor of insulin secretion. , 1990, Endocrinology.

[51]  M. Brownstein,et al.  Insulin receptors are widely distributed in the central nervous system of the rat , 1978, Nature.

[52]  D. Accili,et al.  The forkhead transcription factor Foxo1 regulates adipocyte differentiation. , 2003, Developmental cell.

[53]  D. Accili.  Genetic manipulation of receptor expression and function , 2000 .

[54]  Mark D. Johnson,et al.  Early neonatal death in mice homozygous for a null allele of the insulin receptor gene , 1996, Nature Genetics.

[55]  F. Collins,et al.  The geneticist's approach to complex disease. , 1996, Annual review of medicine.